Tumor–stromal interactions in breast tumor progression – significance of histological heterogeneity of tumor–stromal fibroblasts
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor–stromal interactions in breast tumor progression – significance of histological heterogeneity of tumor–stromal fibroblasts
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 17, Issue 4, Pages 449-460
Publisher
Informa Healthcare
Online
2013-01-09
DOI
10.1517/14728222.2013.757305
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor Endothelial Cells Acquire Drug Resistance by MDR1 Up-Regulation via VEGF Signaling in Tumor Microenvironment
- (2012) Kosuke Akiyama et al. AMERICAN JOURNAL OF PATHOLOGY
- Podoplanin-expressing cancer-associated fibroblasts are associated with poor prognosis in invasive breast cancer
- (2012) Sebastian F. Schoppmann et al. BREAST CANCER RESEARCH AND TREATMENT
- Economic evaluation of the 70-gene prognosis-signature (MammaPrint®) in hormone receptor-positive, lymph node-negative, human epidermal growth factor receptor type 2-negative early stage breast cancer in Japan
- (2012) Masahide Kondo et al. BREAST CANCER RESEARCH AND TREATMENT
- Phase I study of AEE788, a novel multitarget inhibitor of ErbB- and VEGF-receptor-family tyrosine kinases, in recurrent glioblastoma patients
- (2012) David A. Reardon et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Stromal fibroblasts synergize with hypoxic oxidative stress to enhance melanoma aggressiveness
- (2012) Giuseppina Comito et al. CANCER LETTERS
- CCL2 Mediates Cross-talk between Cancer Cells and Stromal Fibroblasts That Regulates Breast Cancer Stem Cells
- (2012) A. Tsuyada et al. CANCER RESEARCH
- Characterization and Clinical Evaluation of CD10+ Stroma Cells in the Breast Cancer Microenvironment
- (2012) C. Desmedt et al. CLINICAL CANCER RESEARCH
- Complete Longitudinal Analyses of the Randomized, Placebo-Controlled, Phase III Trial of Sunitinib in Patients with Gastrointestinal Stromal Tumor following Imatinib Failure
- (2012) G. D. Demetri et al. CLINICAL CANCER RESEARCH
- Clinical experience of using oncotype DX as an additional treatment decision tool in early breast cancer – A retrospective analysis from 5 Greek institutions
- (2012) C. Markopoulos et al. EJSO
- Clinical and functional significance of loss of caveolin-1 expression in breast cancer-associated fibroblasts
- (2012) Samantha A Simpkins et al. JOURNAL OF PATHOLOGY
- Phase-I/II Study of Bortezomib in Combination with Carboplatin and Bevacizumab as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer
- (2012) Bilal Piperdi et al. Journal of Thoracic Oncology
- Fibrotic focus and hypoxia in male breast cancer
- (2012) Robert Kornegoor et al. MODERN PATHOLOGY
- Colorectal Cancer Cells Activate Adjacent Fibroblasts Resulting in FGF1/FGFR3 Signaling and Increased Invasion
- (2011) Maria L. Henriksson et al. AMERICAN JOURNAL OF PATHOLOGY
- Pleural Mesothelioma Instigates Tumor-Associated Fibroblasts To Promote Progression via a Malignant Cytokine Network
- (2011) Qi Li et al. AMERICAN JOURNAL OF PATHOLOGY
- Important Histologic Outcome Predictors for Patients With Invasive Ductal Carcinoma of the Breast
- (2011) Takahiro Hasebe et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Vascular proliferation is a prognostic factor in breast cancer
- (2011) Jarle B. Arnes et al. BREAST CANCER RESEARCH AND TREATMENT
- Modified primary tumour/vessel tumour/nodal tumour classification for patients with invasive ductal carcinoma of the breast
- (2011) T Hasebe et al. BRITISH JOURNAL OF CANCER
- Upregulation of cancer-associated myofibroblasts by TGF-β from scirrhous gastric carcinoma cells
- (2011) Y Fuyuhiro et al. BRITISH JOURNAL OF CANCER
- Phase 2 trial of bevacizumab, capecitabine, and oxaliplatin in treatment of advanced hepatocellular carcinoma
- (2011) Weijing Sun et al. CANCER
- Chemotherapy Enhances Metastasis Formation via VEGFR-1-Expressing Endothelial Cells
- (2011) L. G. M. Daenen et al. CANCER RESEARCH
- Tumor Engraftment in Nude Mice and Enrichment in Stroma- Related Gene Pathways Predict Poor Survival and Resistance to Gemcitabine in Patients with Pancreatic Cancer
- (2011) I. Garrido-Laguna et al. CLINICAL CANCER RESEARCH
- Atypical tumor-stromal fibroblasts in invasive ductal carcinomas of the breast treated with neoadjuvant therapy
- (2011) Takahiro Hasebe et al. HUMAN PATHOLOGY
- Prognostic significance of mitotic figures in metastatic mammary ductal carcinoma to the lymph nodes
- (2011) Takahiro Hasebe et al. HUMAN PATHOLOGY
- RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative, Locally Recurrent or Metastatic Breast Cancer
- (2011) Nicholas J. Robert et al. JOURNAL OF CLINICAL ONCOLOGY
- FHL2 expression in peritumoural fibroblasts correlates with lymphatic metastasis in sporadic but not in HNPCC-associated colon cancer
- (2011) Lucia Gullotti et al. LABORATORY INVESTIGATION
- A mitotically active, cellular tumor stroma and/or inflammatory cells associated with tumor cells may contribute to intermediate or high Oncotype DX Recurrence Scores in low-grade invasive breast carcinomas
- (2011) Geza Acs et al. MODERN PATHOLOGY
- A Phase 3 Trial of Bevacizumab in Ovarian Cancer
- (2011) Timothy J. Perren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Forkhead Box F1 Regulates Tumor-Promoting Properties of Cancer-Associated Fibroblasts in Lung Cancer
- (2010) Roy-Akira Saito et al. CANCER RESEARCH
- Grading system for lymph vessel tumor emboli: significant outcome predictor for invasive ductal carcinoma of the breast
- (2010) Takahiro Hasebe et al. HUMAN PATHOLOGY
- Specific protein and miRNA patterns characterise tumour-associated fibroblasts in bladder cancer
- (2010) Astrid Enkelmann et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer
- (2010) David W. Miles et al. JOURNAL OF CLINICAL ONCOLOGY
- p53 expression in tumor-stromal fibroblasts forming and not forming fibrotic foci in invasive ductal carcinoma of the breast
- (2010) Takahiro Hasebe et al. MODERN PATHOLOGY
- CD90/THY1 is overexpressed in prostate cancer-associated fibroblasts and could serve as a cancer biomarker
- (2010) Lawrence D True et al. MODERN PATHOLOGY
- Interactions with Fibroblasts Are Distinct in Basal-Like and Luminal Breast Cancers
- (2010) J. T. Camp et al. MOLECULAR CANCER RESEARCH
- Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer: Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy
- (2009) Eugenio Maiorano et al. BREAST CANCER RESEARCH AND TREATMENT
- PDGF-C Mediates the Angiogenic and Tumorigenic Properties of Fibroblasts Associated with Tumors Refractory to Anti-VEGF Treatment
- (2009) Yongping Crawford et al. CANCER CELL
- Fibroblast Hepatocyte Growth Factor Promotes Invasion of Human Mammary Ductal Carcinoma In situ
- (2009) C. Jedeszko et al. CANCER RESEARCH
- p53 expression in tumor stromal fibroblasts is associated with the outcome of patients with invasive ductal carcinoma of the breast
- (2009) Takahiro Hasebe et al. CANCER SCIENCE
- Tumor histology in lymph vessels and lymph nodes for the accurate prediction of outcome among breast cancer patients treated with neoadjuvant chemotherapy
- (2009) Nobuko Tamura et al. CANCER SCIENCE
- Fibroblast Growth Factor Receptor 2-Positive Fibroblasts Provide a Suitable Microenvironment for Tumor Development and Progression in Esophageal Carcinoma
- (2009) C. Zhang et al. CLINICAL CANCER RESEARCH
- Crosstalk to Stromal Fibroblasts Induces Resistance of Lung Cancer to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
- (2009) W. Wang et al. CLINICAL CANCER RESEARCH
- CD10+ fibroblasts are more involved in the progression of hilar/extrahepatic cholangiocarcinoma than of peripheral intrahepatic cholangiocarcinoma
- (2009) Yunosuke Nishihara et al. HISTOPATHOLOGY
- p53 expression in tumor-stromal fibroblasts is closely associated with the nodal metastasis and outcome of patients with invasive ductal carcinoma who received neoadjuvant therapy
- (2009) Takahiro Hasebe et al. HUMAN PATHOLOGY
- Attenuated p53 activation in tumour-associated stromal cells accompanies decreased sensitivity to etoposide and vincristine
- (2008) A C Dudley et al. BRITISH JOURNAL OF CANCER
- Fibroblasts Isolated from Common Sites of Breast Cancer Metastasis Enhance Cancer Cell Growth Rates and Invasiveness in an Interleukin-6–Dependent Manner
- (2008) Adam W. Studebaker et al. CANCER RESEARCH
- Gene Expression Profiles Associated with the Presence of a Fibrotic Focus and the Growth Pattern in Lymph Node-Negative Breast Cancer
- (2008) G. G. Van den Eynden et al. CLINICAL CANCER RESEARCH
- Grading system for lymph vessel tumor emboli for prediction of the outcome of invasive ductal carcinoma of the breast
- (2008) Takahiro Hasebe et al. HUMAN PATHOLOGY
- Histopathologic factors significantly associated with initial organ-specific metastasis by invasive ductal carcinoma of the breast: a prospective study
- (2008) Takahiro Hasebe et al. HUMAN PATHOLOGY
- Primary tumor/–vessel tumor/–nodal tumor classification of extrahepatic bile duct carcinoma
- (2007) Takahiro Hasebe et al. HUMAN PATHOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started